Group One Trading
ACOR

Group One Trading’s Acorda Therapeutics ACOR Stock Holding History

Group One Trading’s Portfolio ACOR Stock Details ACOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-204
Closed -$3.07K – 8678
2023
Q2 		$2.65K Sell
204
-124
-38% -$1.47K ﹤0.01% 6997
2023
Q1 		$3.84K Sell
328
-149
-31% -$2.48K ﹤0.01% 6391
2022
Q4 		$7.32K Buy
+477
New +$5.56K ﹤0.01% 6164
2021
Q1 		– Sell
-984
Closed -$121K – 8183
2020
Q4 		$81K Buy
+984
New +$90.5K ﹤0.01% 4712
2020
Q3 		– Sell
-731
Closed -$55.1K – 6697
2020
Q2 		$64K Buy
+731
New +$77.3K ﹤0.01% 4208
2019
Q2 		– Sell
-33
Closed -$40.6K – 5540
2019
Q1 		$53K Buy
+33
New +$59.5K ﹤0.01% 3539
2018
Q1 		– Sell
-110
Closed -$329K – 5443
2017
Q4 		$283K Buy
110
+66
+150% +$188K ﹤0.01% 2689
2017
Q3 		$126K Buy
+44
New +$116K ﹤0.01% 3080
2016
Q3 		– Sell
-98
Closed -$292K – 5018
2016
Q2 		$301K Sell
98
-22
-18% -$71.6K ﹤0.01% 2120
2016
Q1 		$381K Buy
+120
New +$498K 0.01% 1879
2013
Q3 		– Sell
-7
Closed -$30.2K – 5695
2013
Q2 		$26K Buy
+7
New +$28.8K ﹤0.01% 3923

Other funds holding ACOR

DKCM
Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Group One Trading's ACOR Position: Q3 2023 in Review

Group One Trading sold out of Acorda Therapeutics (ACOR) in Q3 2023, closing a stake of 204 shares — an estimated $3.07K sold.

Group One Trading first reported a position in ACOR in Q2 2013 and held it in 11 quarters. The position peaked at $381K in Q1 2016. 16 funds tracked by Wall St. Rank hold ACOR as of Q3 2023.

  • Group One Trading reported no remaining Acorda Therapeutics position as of Q3 2023 after selling out during the quarter.
  • Group One Trading sold 204 Acorda Therapeutics shares in Q3 2023, an estimated $3.07K.
  • Group One Trading first reported a position in Acorda Therapeutics in Q2 2013 and held it in 11 quarters.
  • Group One Trading's Acorda Therapeutics position peaked at $381K in Q1 2016.
  • 16 funds tracked by Wall St. Rank held Acorda Therapeutics as of Q3 2023.

Based on Group One Trading's 13F filing for Q3 2023, filed 9 Nov 2023.